View Cart  

Feb. 9, 2005

Vol. 2 No. 28

View Archived Issues

Sign Up Now

FDA Proposes $1.9 Billion Budget for Fiscal 2006

The FDA has released highlights of its fiscal 2006 budget request to Congress totaling $1.9 billion, including $1.5 billion in budget authority and $382 million in congressionally authorized industry user fees -- 50 percent higher than the appropriations in fiscal 2001 and a 4.5 percent increase over the fiscal 2005 level.

Read More

FDA Warns Consumers Not to Use Globus Media's Diagnostic Kits

The FDA warned consumers not to use unapproved home-use diagnostic test kits that have been marketed nationwide via the internet by Globus Media, Montreal, Canada.

Read More

Align Technology Acquires General Orthodontic

Align Technology, the inventor of Invisalign -- a proprietary method of straightening teeth without wires and brackets has announced the acquisition of General Orthodontic (GO) as part of the company's ongoing commitment to providing clinical support for Invisalign doctors.

Read More

B. Braun Introduces the LidoSite Topical System

B. Braun announced the availability of the LidoSite Topical System, a method to help reduce needlestick pain associated with procedures such as intravenous cannulation, venipuncture or laser ablation of superficial skin lesions for patients ages 5 and up.

Read More

M.D. Anderson Grants Exclusive License to Quest Diagnostics

The University of Texas M.D. Anderson Cancer Center has granted an exclusive license to Quest Diagnostics for the use of five proprietary blood testing methods that have the potential to eliminate the need for painful and expensive bone marrow and other tissue extractions.

Read More

Medical Device Bill Introduced in House

Having survived the Utah Senate, a bill holding reprocessors of "single-use" medical devices completely liable for the recycled products' safety could come to a final House vote within a week.

Read More

Biomerica Launches New Diabetes Diagnostic Test

Biomerica has announced it is launching a new diabetes diagnostic blood test to measure levels of C-peptide in blood. C-peptide levels in blood are about five to six times greater than insulin levels and are more stable.

Read More

Chindex Announces Award of 8.1 Million Euros in Supply Packages

Chindex International, an independent American distributor of Western healthcare products and services in China, has announced that its German subsidiary, Chindex China-Export, has been awarded a contract to supply medical equipment to hospitals in two Chinese provinces under a financing arrangement sponsored by the German government and funded by KfW Development Bank.

Read More

Cambridge Heart Announces REFINE Study Enrollment Completed

Cambridge Heart has announced that the "Risk Estimation Following Infarction -- Noninvasive Evaluation Study (REFINE) has completed its enrollment of 350 patients.

Read More

Visiomed Appoints New CEO

Visiomed has announced the appointment of William Dolphin as CEO, replacing the retiring Saliba Sassine who has accepted a non executive board position and will remain a major shareholder.

Read More

ISME Announces a Joint Marketing Agreement With BioTech

International Sports and Media Group (ISME) has announced its joint marketing agreement with BioTech Medics (BTMD).

Read More

EBI Introduces the New Pro Osteon Line of Osteobiologics

EBI has introduced a new line of Osteobiologics: Pro Osteon Osteobiologics. In addition to Traditional Allograft, Resorbable Granules and Blocks, Synthetic Bone Graft Substitutes and DBM Putty, the new Pro Osteon line now includes: DBM Paste, Bone Marrow Aspirate and Concentrators, Bone Void Fillers and Machined Graft Substitutes.

Read More